Executive Vice President � Corporate Development
, Recipharm
Mark Quick, is responsible for leading Recipharm’s merger and acquisition (M&A) activities. He has been with the company for over 12 years and been an integral part of the international growth ...
Torsten Türling, CEO of the Syntegon Group, and Jordi Puig, Managing Director of Telstar, celebrate an important strategic milestone: Syntegon and Telstar have officially joined forces to offer custo...
Morten Nielsen is a senior partner in WittKieffer’s Global Life Sciences Practice. He has more than 30 years of experience as a life sciences industry executive and leadership recruiter....
Nigel Theobald, Chief Executive Officer at N4 Pharma, has over 25 years’ experience in healthcare and in building businesses, strategy development and its implementation and a strong network cov...
Cem Zorlular is CEO of Er-Kim, a local partner and advisor to leading biopharmaceutical companies commercializing new treatments in international markets. A third-generation representative of Er-Kim, ...
Giancarlo owns a PhD in natural sciences and a MBA with a thesis focus on Roadmap to IPO, boasts nearly 25 years of global management experience in globally leading healthcare companies. With leadersh...
Markus Heinz is product manager vials at Syntegon Technology. He has a bachelor’s degree in industrial and mechanical engineering as well as a master’s degree in international management. He joine...
We use cookies to give you the best experience. By continuing to use this site you consent to the use of cookies, unless disabled from your browser. OkPrivacy policy